Back
Day Range
$40.50
$42.02
52-Week Range
$30.08
$62.18
Volume
384,872
50D / 200D Avg
$41.39
/
$47.11
Prev Close
$42.11
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.1 | 0.4 |
| P/B | 8.5 | 2.9 |
| ROE % | -132.9 | 3.7 |
| Net Margin % | -89.9 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$56.88
+39.0%
Low: $50.00
High: $68.00
Forward P/E
21.7
Forward EPS
$1.94
EPS Growth (est.)
+0.0%
Est. Revenue
740 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.79
$3.68 – $3.93
|
1.4 B | 1 |
| FY2029 |
$3.38
$3.29 – $3.50
|
1.2 B | 1 |
| FY2028 |
$3.01
$2.81 – $3.21
|
1 B | 2 |
Key Takeaways
Debt/Equity of 0.02 — conservative balance sheet
Generating 170.73M in free cash flow
Capital efficient — spends only 0.12% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)50.58%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-132.86%
ROIC-106.00%
Net Margin-89.86%
Op. Margin-92.94%
Safety
Debt / Equity
0.02
Current Ratio1.47
Interest Coverage0.00
Valuation
P/E Ratio
-6.10
P/B Ratio8.51
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 50.58% | Revenue Growth (3Y) | 41.71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 587.86M | Net Income (TTM) | -528.26M |
| ROE | -132.86% | ROA | -70.93% |
| Gross Margin | 79.65% | Operating Margin | -92.94% |
| Net Margin | -89.86% | Free Cash Flow (TTM) | 170.73M |
| ROIC | -106.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 1.47 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.10 | P/B Ratio | 8.51 |
| P/S Ratio | 5.48 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.22B | Enterprise Value | 3.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 587.86M | 390.40M | 292.73M |
| Net Income | -528.26M | -11.93M | -108.14M |
| EPS (Diluted) | -5.19 | -0.15 | -1.39 |
| Gross Profit | 468.22M | 300.59M | 194.18M |
| Operating Income | -546.37M | -24.43M | -130.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 744.76M | 673.26M | 622.53M |
| Total Liabilities | 366.23M | 256.56M | 195.25M |
| Shareholders' Equity | 378.54M | 416.70M | 427.28M |
| Total Debt | 8.04M | 11.07M | 15.73M |
| Cash & Equivalents | 208.00M | 300.79M | 234.95M |
| Current Assets | 533.90M | 583.45M | 529.88M |
| Current Liabilities | 362.41M | 249.30M | 184.16M |